Co-crystals
AssigneeCereSpir Incorporated
InventorsDaniel G. Chain, Ronald Mueller
Life of this patent
Estimating the term…
Abstract
Co-crystals of itanapraced; methods of preparation of the co-crystals; uses of the co-crystals as APIs; formulations containg the co-crystals; uses of the co-crystals and formulations for prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries; and methods of prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries are described.
Claims20
A method of treating a neurodegenerative condition in a human, comprising administering a therapeutically effective dosage regimen of a co-crystal comprising itanapraced and a coformer selected from a group consisting of a group consisting of nicotinamide, picolinamide, isonicotinamide, isonicotinic acid, and nicotinic acid.
A method of treating oxidative stress in a human, comprising administering a therapeutically effective dosage regimen of a co-crystal comprising itanapraced and a coformer selected from a group consisting of a group consisting of nicotinamide, picolinamide, isonicotinamide, isonicotinic acid, and nicotinic acid.
A method of treating a neurodegenerative condition in a human, comprising administering a therapeutically effective dosage regimen of a co-crystal comprising a praced and a coformer comprising nicotinamide.
The method of claim 19, wherein the praced is itanapraced.
Dependencies are inferred from the claim text.